Dallas-based Taysha Gene Therapies to receive $50M investment from Japanese pharmaceutical company

The investment will go towards Taysha's adeno-associated virus gene therapy development programs for the treatment of Rett syndrome and giant axonal neuropathy.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 25, 2022 Category: Pharmaceuticals Authors: DBJ staff Source Type: news